Tactical, Operational & Strategic Analysis of Markets, Competitors & Industries
Using Active Pharmaceutical Ingredient Manufacturing Intel
March 19 - 19, 2009
12 Noon to 1:00PM USA EST
Using Active Pharmaceutical Ingredient Manufacturing Intelligence to Forecast and Analyze Generic Competition for Pharmaceutical Products Worldwide
This session examines why it is crucial for competitive intelligence and lifecycle management professionals to regularly and actively review the activities of companies developing generic active pharmaceutical ingredients (APIs) as the earliest and most reliable indicator of future generic competition for their, or their competitor’s products.